| Matthew S Ricke, PHARMD | |
|
601 Main St, Wellsville, KS 66092-9201 | |
| (785) 883-2462 | |
| Not Available |
| Full Name | Matthew S Ricke |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 601 Main St, Wellsville, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659723112 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 1-16707 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Matthew S Ricke, PHARMD 5006 Rosehill Dr, Shawnee, KS 66216-1258 Ph: (620) 440-1423 | Matthew S Ricke, PHARMD 601 Main St, Wellsville, KS 66092-9201 Ph: (785) 883-2462 |
News Archive
For the first time, serotonin (5-hydroxytryptamine, 5-HT) has been directly implicated in the pathophysiology of rheumatoid arthritis (RA). Although 5-HT is predominantly known as a neurotransmitter within the central nervous system, new evidence points to additional important functions for serotonin in the periphery.
Breastfeeding women and their infants produce a substance that increases sexual desire among other women, according to research at the University of Chicago.
Elan Corporation, plc announced today that Pfizer has issued a top-line result in the first of four Bapineuzumab Phase 3 studies carried out by Pfizer and Janssen AI.
Obese atrial fibrillation patients have a lower chance of arrhythmia recurrence if they have high levels of cardiorespiratory fitness, and risk continues to decline as exercise capacity increases as part of treatment, according to a study published today in the Journal of the American College of Cardiology.
Allos Therapeutics, Inc. today reported results from a retrospective analysis of data from the Company's pivotal PROPEL trial which suggested that treatment with single-agent FOLOTYN may result in increased response rates and progression-free survival relative to the immediate prior line of therapy in patients with relapsed or refractory peripheral T-cell lymphoma.
› Verified 2 days ago
Dr. Kaylene Stanton, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 601 S Main St, Wellsville, KS 66092 Phone: 785-883-2462 |